|Jury selection began Monday in the securities fraud trial of Martin Shkreli, the widely reviled 34-year-old former pharmaceutical company leader also known as “pharma bro.” Shkreli gained national notoriety as CEO of Turing Pharmaceuticals by hiking the price for a life-saving drug for AIDS patients by 5,000 percent. Prosecutors say that before that he swindled through his hedge fund. Federal agents arrested him in December 2015. The Securities and Exchange Commission accused him of committing a “series of frauds” from October 2009 to March 2014. In interviews, potential jurors told Judge Kiyo Matsumoto they thought Shkreli was “evil” and “a snake.” “I have total disdain for the man,” one juror said.
Source: NPR, Ars Technica